Biosimilars

Biosimilars

Biosimilar Development, Review and Approval

Biological products are the fastest-growing class of therapeutic products in the United States. When patients are prescribed a biological product, biosimilar and interchangeable products can offer additional treatment options, potentially lowering health care costs. FDA tasked out team to develop a series of short video to give an overview of biosimilars and the FDA approval process.

Client:
U.S. Food and Drug Administration

Date:
2017

Credits:
Art Director: Simon Fong ▪ Illustrators: Freddy Trejo and Ale Rodriguez-Gitler ▪ Animator/Editor: David Arbor

The Promise of Biosimilars

The Basics of Biosimilars

The Concept of Interchangeability

The Biosimilar Development Process

Analytical Data for Biosimilar Products

Simon Fong
Creative + Art Direction

simon@simonfong.com
+1.202.230.6041

Copyright 2018
Simon Fong